evidence: In patients with a high disease activity at baseline, the clinical efficacy of abatacept was similar to adalimumab and tocilizumab.
intervention:  abatacept
comparator: adalimumab
outcome: treatment of RA (Rheumatoid arthritis) patients with a high disease activity at baseline